Lilly Announces Initiation of IXORA-R Head-to-Head Trial Comparing Taltz ® and Tremfya ® in Patients with Moderate-to-Severe Plaque Psoriasis

  • Alice Gottlieb

Press/Media

Period10 Sep 2018

Media coverage

1

Media coverage